Loading chat...
PA HB1741
Bill
Status
Introduced
7/30/2021
Primary Sponsor
Dawn Keefer
Click for details
AI Summary
Legislative Description
Providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.
Last Action
Re-committed to APPROPRIATIONS
6/14/2022
Committee Referrals
Appropriations6/14/2022
Health7/30/2021
Full Bill Text
No bill text available